Activity Overview
In this online, on-demand activity, faculty experts focus on the role of pharmacologic therapies in managing presbyopia. Pharmacologic therapies offer noninvasive, reversible approaches for correcting near vision that enhance depth of focus, but putting them to use clinically calls for a thorough grasp of how they influence pupil size, along with their safety profiles and duration of effect.
This educational symposium pairs case presentations with expert discussion to build a more nuanced view of how these agents compare, keeping treatment decisions both evidence-driven and patient-centered. This educational activity is an archive of the live symposium held on October 2, 2026.
Target Audience
This educational activity is directed toward optometrists and other eye care professionals involved in the care of patients experiencing presbyopia.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Describe the mechanisms of action, efficacy, durability, and safety of topical pharmacologic agents for presbyopia
- Integrate clinical evidence to identify appropriate patients for topical pharmacologic therapies for presbyopia
- Apply evidence-based counseling strategies to establish realistic expectations for topical presbyopia therapies
Mile Brujic, OD, FAAO
Premier Vision Group
Bowling Green, OH
Disclosures: Advisor, Consultant, Speaker, Honoraria Recipient: ABB Optical, AbbVie, Alcon, Apellis, Art Optical, Bausch + Lomb Health, Contamac, CooperVision, CS Eye, Dompé, Dopavision, Glaukos, Iveric Bio, Johnson & Johnson Vision Care, Lentechs, MDelite, Nordic Pharma, Notal Vision, Orasis, RadiusXR, RVL, Sun Pharma, Tangible Science, Tarsus, Viatris, Visionix, Walman Optical, ZeaVision
Melissa Barnett, OD, FAAO, FSLS, FBCLA
Doctor of Optometry, Baker Optometry
CEO, Alpine Blue Coaching
Sacramento, CA
Disclosures: Advisor, Consultant, Speaker, Honoraria Recipient: ABB Optical, AbbVie, Alcon, Azura Ophthalmics, Bausch + Lomb, BCLA, Bruder Healthcare, Bruno Vision Care, Cloudbreak Pharma, Dompé, Epion, Gas Permeable Lens Institute, OCuSOFT, ScienceBased Health, STAPLE program, Tarsus, Tenpoint, Théa Pharma; Executive Role (CEO, Founder): Alpine Blue Coaching, EyeVida; Other (Podcast): National Keratoconus Foundation
Tracy Swartz, OD, MS, FAAO
Consultative Optometrist
VisionAmerica
Scottsboro, AL
Disclosures: Advisor, Consultant, Speaker, Honoraria Recipient: Ace Vision Group, Glaukos
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible companies.
PER® mitigated all conflicts of interest for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This accredited continuing education activity was planned in accordance with the ACCME Standards for Integrity and Independence to ensure balance, objectivity, independence, and scientific rigor. Faculty were instructed to use generic names when possible and to base recommendations on the best available evidence. Proprietary product names may be referenced in clinical discussion for educational purposes only and do not imply endorsement.
This activity may include discussion of investigational, unapproved, or off‑label uses of drugs or devices. Learners are advised to consult prescribing information for products discussed. Content is provided for educational purposes only and is not a substitute for the independent clinical judgment of a health care professional. Learners are encouraged to critically evaluate the information presented and apply their own clinical judgment.
The views expressed are those of the individual faculty members and do not necessarily reflect the views of the accredited provider or any entity providing commercial support.
This activity may have used AI-assisted tools to support educational development. All content was reviewed and approved by qualified faculty or planners. The accredited provider retains full responsibility for accuracy, balance, and independence.